Keywords: SM; systemic mastocytosis; AHNMD; associated clonal haematological non-mast cell lineage disease; CM; cutaneous mastocytosis; RTK; receptor tyrosine kinase; MDS; myelodysplastic syndrome; MPN; myeloproliferative syndrome; AML; acute myeloid leukaemia.; Ma